Navigation Links
Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being
Date:4/16/2008

Study Published in April 2008 Issue of Contraception

KENILWORTH, N.J., April 16 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today announced results of a recently completed study showing that non-compliance with combined hormonal contraceptives has noticeable effects on women's emotional well-being, prompted requests for physicians' advice and led to increased use of emergency contraception. Results were presented today in Madrid, Spain, and were published earlier this month in Contraception.

The cross-sectional, multi center study was designed to assess the self-described impact of noncompliant behavior among 26,250 current users, aged 18 to 49, of three combined hormonal contraceptive methods, the combined pill, the skin patch and NUVARING(R) (etonogestrel/ethinyl estradiol vaginal ring), the vaginal ring.

"The study included questions about attitudes and psychological impact of inconsistent use of the contraceptive method when confronted with noncompliant behavior, an issue that has been poorly characterized in previous studies," commented Dr Inaki Lete, Hospital Santiago Apostol, Vitoria-Gasteiz, Spain and lead investigator. "These considerations will help health-care professionals to empower women to increase compliance with the prescribed contraceptive regimens."

The study found that 71 percent of pill users, 32 percent of patch users and 21.6 percent of ring users reported noncompliant behavior ( p<0.0001 for all comparisons). Between 10 and 20 percent of women reported that noncompliant behavior with their current method negatively affected work activities and their relationship with their partner, and about 3 percent had missed days of work or school. A higher percentage of pill users reported that they were 'worried' or 'scared' (68.8 percent and 22.6 percent respectively) compared with women using the skin patch (61.7 percent and 19 percent) or the vaginal ring (58.3 percent and 16.4 percent) (p<0.0001).
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
4. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
5. Schering-Plough Reports Top-Line Results of the IDEAL Study
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... NEW YORK and LONDON ... distributor of market intelligence, MarketResearch.com is pleased to announce ... Research and Consultancy focusing on the active pharmaceutical ingredient ... Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . In ... Market – Forecast to 2020 , ...
(Date:11/26/2014)... , Nov. 25, 2014  goBalto, Inc., the ... been recognized as a winner of Red Herring,s ... Global Top 100 North America award in 2013, marking ... technology landscape. Red Herring,s Top 100 Global ... promising new companies and entrepreneurs. Red Herring editors were ...
(Date:11/26/2014)... , Nov. 25, 2014 Nanomix ... on the development of mobile diagnostic tests ... in hospital and pre-hospital settings, today announced ... 13485:2003 certification.  The certification was awarded by ... the world,s leading certification bodies. ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3Nanomix Receives ISO 13485:2003 Certification 2
... DIEGO, Oct. 26 The ... Circle at their Annual Scientific Meeting, becoming the first medical association ... collaborative community. Meeting attendees, authors and presenters can, for the ... latest breakthroughs in clinical gastroenterology during -- and well after -- ...
... 26 Sequenom, Inc. (Nasdaq: SQNM ), today ... the company,s interim chief financial officer effective November 10, ... officer and chairman of the board, Harry F. Hixson, ... Prior to the effective date of Mr. Maier,s appointment ...
Cached Medicine Technology:American College of Gastroenterology to Revolutionize Scientific Exchange on Within3 2American College of Gastroenterology to Revolutionize Scientific Exchange on Within3 3Sequenom Announces Paul Maier to Become Interim Chief Financial Officer 2Sequenom Announces Paul Maier to Become Interim Chief Financial Officer 3
(Date:11/27/2014)... Cambrionix Ltd today announced that it ranked number 10 in ... 50 fastest-growing technology companies in the UK. Rankings are ... Cambrionix Ltd grew 2989 percent during this period. ... Cambridgeshire and East and first in the sector of Electronics. ... of the hard work put in by our team who ...
(Date:11/27/2014)... 27, 2014 Blood-borne pathogens raise the ... precautions and procedures in place to counter this. However, ... of things tainted with menstrual blood are taken as ... simpler, more sanitary way to handle tampons and menstrual ... from Sonora, Calif. , He then created a prototype ...
(Date:11/27/2014)... PA (PRWEB) November 27, 2014 "As ... the embarrassing side effects of urinary incontinence," said an ... it and developed this specialized accessory to prevent leakage ... the Incontinence to absorb urine leakage. This prevents stains ... from potential embarrassment. The pad ensures that the individual ...
(Date:11/27/2014)... By Randy Dotinga ... -- Some people,s brains seem pre-wired to acquire a second ... beyond their mother tongue will likely gain a brain boost, ... connected and integrated after learning," said study co-author Ping Li, ... Pennsylvania State University. But it,s even more interesting, Li said, ...
(Date:11/27/2014)... HealthDay Reporter WEDNESDAY, Nov. ... to be safe and produces an immune system response that ... clinical trial results reported by the U.S. National Institutes of ... for the vaccine paves the way for field-testing it in ... as early as January, said Dr. Anthony Fauci, director of ...
Breaking Medicine News(10 mins):Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 2Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 3Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 4Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3
... of prostate cancer is common among older men. Being the ... it is the second leading cause of cancer deaths in ... been a increase in number of detected cases. Most men ... and a prostate-specific antigen (PSA) blood test. In rectal exam ...
... found that women with breast cancer are more likely ... blood. A residue of the fungicide hexachlorobenzene (HCB) were ... that DDT or HCB actually cause breast cancer. The ... for mosquito control in developing countries. DDT, HCB and ...
... a study drinking tea on regular basis help protect ... an increased rate of survival following a heart attack.,Researchers ... group of antioxidants known as,flavonoids, which are plentiful in ... in certain fruits and vegetables, including apples, onions, and ...
... found that evening administration of the central alpha(2)-agonists ... in the morning in hypertensive patients. The study ... to receive once-daily evening administration of guanabenz or ... effects of the two drugs in the morning ...
... Researchers at an American university have found that ... chemical. When one chew broccoli, its cells rupture ... sulphoraphanes. To simulate chewing the researchers crushed raw ... Researchers said that broccoli obtained from common supermarket ...
... question of whether daily moderate exercise could actually prevent ... like jogging, hiking, climbing stairs, racket sports and swimming ... from heart disease. Recommendations in the United States and ... walking, is sufficient for good heart health.// A World ...
Cached Medicine News:
... use. Kit comprises: 1 Miller 0 Premature; 1 Miller ... Ad.; 1 Mac 2 Child; 1 Mac 3 Medium ... Standard, 1 Nylon Carrying Case. The Lite Blade Kit ... take your disposable laryngoscopes anywhere. Each blade and handle ...
... The Flipper® is a unique fiberoptic ... bit of anterior exposure sometimes needed during ... the end of the blade to be ... the handle. This one-handed operation produces a ...
... fiberoptic Naso-Pharyngo-Laryngoscope provides a new standard in ... latest in Fujinon engineering combines high resolution ... a wide 90 degree field of view ... diameter. In addition, the FR-120F offers ...
... CCR Medical's Articulating Tip Laryngoscopes ... in the Industry. The articulating ... by providing an improved view ... and Fiber Optic styles. We ...
Medicine Products: